Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors, antagonists |
Mechanism NR1D1 inhibitors(Nuclear receptor subfamily 1 group D member 1 inhibitors), NR1D2 antagonists(Nuclear receptor subfamily 1 group D member 2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Muscle injury | Preclinical | United States | 23 Dec 2025 | |
| Muscle injury | Preclinical | United States | 23 Dec 2025 |





